Molecular Sexually Transmitted Pathogens

This program, developed in 2022, features simulated swabs and urine samples and expands routine testing beyond Ct/Ng to a broader range of STIs. It can detect drug-resistant organisms, enabling laboratories to stay ahead in identifying and addressing emerging challenges in STI diagnostics.